|
(±)-(R*)-alpha-[(R*)-2-(Dimethylamino)propyl]-alpha-phenyl-2-pyridineacetamide; (±)-(2R*,4R*)-4-(Dimethylamino)-2-phenyl-2-(2-pyridyl)pentanamide |
132373-81-0 |
C18H23N3O |
|
2-Methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine |
132539-06-1 |
C17H20N4S |
|
2-[Acetyl-(N-methyl)isoleucyl-isoleucyl-threonyl-leucyl]-2(R)-methyloxyrane |
134381-21-8 |
C28H50N4O7 |
|
(E)-2-Cyano-N,N-diethyl-3-(3,4-dihydroxy-5-nitrophenyl)propenamide; (E)-2-Cyano-N,N-diethyl-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide; (E)-alpha-Cyano-N,N-diethyl-3,4-dihydroxy-5-nitrocinnamamide |
130929-57-6; 133180-79-7 ([14C]-labeled); 116314-6 |
C14H15N3O5 |
|
Cyclo-[[N-methyl-3-oxo-5-[1(E)-propenyl]]-L-leucyl-L-valyl-sarcosyl-(N-methyl)-L-leucyl-L-valyl-(N-methyl)-L-leucyl-L-alanyl-D-alanyl-(N-methyl)-L-leucyl-(N-methyl)-L-leucyl-(N-methyl)-L-valine]; 6-[[R-(E)]-6,7-Didehydro-N,4-dimethyl-3-oxo-L-2-aminooctan |
121584-18-7 |
C63H111N11O12 |
|
(2R,3S)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol |
137234-62-9 |
C16H14F3N5O |
|
4-[3-[3-[Bis(4-isobutylphenyl)methylamino]benzoyl]indol-1-yl]butyric acid |
163136-03-6; 139155-45-6 (monoHCl); 139155-29-6 (m |
C40H44N2O3 |
|
trans-1,2-Bis(5-amidino-2-benzimidazolyl)ethene tetrahydrochloride; (E)-2,2′-Vinylenebis(benzimidazole-5-carboxamidine) tetrahydrochloride |
|
C18H16N8.4ClH |
|
(+)-(R)-1-[1-[2-(4-Fluorophenyl)ethyl]piperidin-4-yl]-1-(2,3-dimethoxyphenyl)methanol; (+)-(R)-alpha-(2,3-Dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol |
139290-65-6; 139290-69-0 (racemate) |
C22H28FNO3 |
|
4-Amino-3-isobutylbutyric acid; 3-(Aminomethyl)-5-methylhexanoic acid |
128013-69-4 |
C8H17NO2 |